13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 70 holding rows worth $4,930,699,654.
- Accession
- 0001104659-23-021847
- Filer
- CIK 1346824
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 70 entries on the cover page, a total value of $4,930,699,654 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,930,699,654 with VALUE read as dollars as filed, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 6,957,179 | $849,680,271 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 5,857,459 | $280,865,159 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 8,263,982 | $242,134,673 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 6,848,911 | $213,686,023 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 6,317,990 | $165,089,079 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 5,516,067 | $160,627,871 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 7,040,622 | $151,514,185 | dollars as filed | |
| VOR BIOPHARMA INC | 929033108 | COM | 22,748,880 | $151,280,052 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 532,892 | $147,568,453 | dollars as filed | |
| CYTEK BIOSCIENCES INC | 23285D109 | COMMON STOCK | 13,381,054 | $136,620,561 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 2,436,223 | $121,616,252 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 5,454,533 | $121,036,087 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 17,202,009 | $120,414,063 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 8,670,644 | $114,192,381 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 8,955,410 | $114,002,369 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 8,131,952 | $108,724,198 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 21,853,958 | $108,395,632 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 12,452,574 | $102,360,158 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 3,853,867 | $94,959,283 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 2,075,000 | $92,482,750 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 4,417,259 | $86,269,068 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 3,984,681 | $83,797,841 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 5,999,481 | $69,354,000 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 4,398,453 | $69,275,635 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 9,505,925 | $69,203,134 | dollars as filed | |
| ACRIVON THERAPEUTICS INC | 004890109 | CMN | 4,810,508 | $55,417,052 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 7,236,454 | $54,997,050 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 9,770,773 | $52,762,174 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 958,980 | $52,552,104 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 13,150,849 | $48,263,616 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 4,898,373 | $47,612,186 | dollars as filed | |
| ICOSAVAX INC | 45114M109 | COM | 5,963,565 | $47,350,706 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 2,407,149 | $47,107,906 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 7,805,129 | $46,752,723 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 4,000,000 | $43,600,000 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 3,052,796 | $38,678,925 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 3,773,517 | $35,961,617 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 4,397,368 | $32,320,655 | dollars as filed | |
| GERON CORP | 374163103 | COM | 12,930,711 | $31,292,321 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,971,231 | $30,484,830 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 1,760,019 | $29,445,118 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 4,264,144 | $26,011,278 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 880,000 | $25,704,800 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 3,009,678 | $25,672,553 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,400,001 | $19,614,014 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 3,426,286 | $18,433,419 | dollars as filed | |
| DA32 LIFE SCNCE TEC ACQSTN C | 23312M106 | CLASS A COM | 1,500,000 | $14,992,500 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 1,856,904 | $13,314,002 | dollars as filed | |
| IMARA INC | 45249V107 | COM | 3,250,724 | $13,295,461 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 6,067,483 | $12,195,641 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 3,370,506 | $11,796,771 | dollars as filed | |
| ARYA SCIENCES ACQUISITN CORP | G31658100 | CLASS A ORD SHS | 1,000,000 | $10,090,000 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 4,291,881 | $8,798,356 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 590,218 | $7,572,497 | dollars as filed | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 1,088,296 | $6,355,649 | dollars as filed | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 610,283 | $6,090,624 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 6,991,003 | $6,066,792 | dollars as filed | |
| ATHIRA PHARMA INC | 04746L104 | COM | 1,881,300 | $5,963,721 | dollars as filed | |
| SATSUMA PHARMACEUTICALS INC | 80405P107 | COM | 5,914,252 | $5,322,827 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 275,000 | $5,046,250 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,589,904 | $4,661,827 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 1,958,957 | $2,997,204 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 1,127,260 | $2,592,698 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 534,687 | $2,299,154 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 659,992 | $2,078,975 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,607,834 | $1,447,051 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 143,900 | $1,146,883 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 632,184 | $885,058 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 333,333 | $289,433 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 295,966 | $216,055 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-23-021847 | this filing | 2023-02-14 | acceptance time not in the bulk data set |